Physician profile
Christopher A Winter
NPI 1982043824
$2,908.58
in general payments reported to CMS, 2019-2025
33 companies · $619 in 2025
The $619 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $468 · 2020: $165 · 2021: $13.40 · 2022: $326 · 2023: $841 · 2024: $476 · 2025: $619.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,936.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,935.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $321.33 | 2019-2025 | Xtandi |
| Pfizer INC. | $306.45 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $273.43 | 2023-2025 | Orgovyx, Gemtesa |
| Bayer Healthcare Pharmaceuticals INC. | $237.23 | 2019-2025 | |
| Boston Scientific Corporation | $212.52 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $207.81 | 2022-2025 | Lynparza, Keytruda, Welireg |
| Abbvie INC. | $207.81 | 2022-2025 | Botox |
| Procept Biorobotics Corporation | $189.08 | 2023 | Aquabeam Robotic System |
| Janssen Biotech, INC. | $163.68 | 2022-2025 | Erleada, Akeega, Balversa |
| Avanos Medical | $89.75 | 2025 | On-Q Pump and Accessories |
| Urogen Pharma, INC. | $87.64 | 2022-2024 | Jelmyto |
| Endo Pharmaceuticals INC. | $66.58 | 2019-2023 | Xiaflex, Aveed, Edex |
| Dendreon Pharmaceuticals LLC | $54.39 | 2019-2025 | Provenge |
| Novartis Pharmaceuticals Corporation | $48.02 | 2022-2025 | |
| Astrazeneca Pharmaceuticals LP | $46.34 | 2023-2024 | Lynparza |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Antares Pharma, INC. | $45.47 | 2019-2023 | Tlando, Xyosted, Nocdurna |
| Blue Earth Diagnostics | $40.47 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $32.18 | 2024 | |
| Tempus Ai, INC | $29.36 | 2025 | Xt Cdx |
| Amgen INC. | $28.23 | 2019 | |
| Palette Life Sciences, INC. | $22.20 | 2023 | |
| Ferring Pharmaceuticals INC. | $21.53 | 2025 | Adstiladrin |
| Ethicon US, LLC | $20.29 | 2024 | Enseal |
| Sagent Pharmaceuticals | $18.65 | 2024 | Glydo |
| Teleflex LLC | $18.01 | 2024 | Urolift |
| Olympus America INC. | $17.68 | 2023 | Itind System |
| Laborie Medical Technologies Corp. | $17.68 | 2025 | Optilume Bph Drug Coated Balloon Catheter |
| Tolmar, INC. | $17.67 | 2023 | |
| Alnylam Pharmaceuticals INC. | $14.77 | 2025 | Givlaari |
| Myriad Genetic Laboratories, INC. | $14.26 | 2022 | |
| Calyxo, INC. | $14.04 | 2025 | Cvac Aspiration System |
| Myovant Sciences INC. | $12.26 | 2022 | |
| Sun Pharmaceutical Industries INC. | $11.77 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Winter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.